(SSSS) SuRo Capital - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NASDAQ (USA) | Market Cap: 274m USD | Total Return: 174.4% in 12m
Industry Rotation: +5.5
Avg Turnover: 2.52M USD
Peers RS (IBD): 96.6
EPS Trend: 33.2%
Qual. Beats: 0
Rev. Trend: 27.6%
Qual. Beats: 2
Warnings
Share dilution 20.4% YoY - potential capital distress
Tailwinds
No distinct edge detected
SuRo Capital Corp. (SSSS) is a Business Development Company (BDC) that invests in late-stage, venture-backed private companies. BDCs are regulated investment companies that provide capital to small and mid-sized companies.
The firm focuses on growth capital investments across sectors such as technology, media, communication, energy, and consumer. Venture capital firms typically invest in companies with high growth potential.
Geographically, SuRo Capital Corp. targets investments in the United States and Canada. The company exclusively seeks minority equity stakes in its portfolio companies.
For more detailed financial analysis and performance metrics, further research on platforms like ValueRay is recommended.
- Venture capital investment performance impacts portfolio valuation
- Exits from private companies drive realized gains
- Investment in technology and media sectors influences returns
- Interest rate changes affect cost of capital
| Net Income: 48.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.54 > 1.0 |
| NWC/Revenue: 109.6m% < 20% (prev 429.2%; Δ 109.6m% < -1%) |
| CFO/TA -0.00 > 3% & CFO -16.2m > Net Income 48.8m |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.8m) vs 12m ago 20.45% < -2% |
| Gross Margin: 62.89% > 18% (prev -0.04%; Δ 6.29k% > 0.5%) |
| Asset Turnover: 0.00% > 50% (prev 2.02%; Δ -2.02% > 0%) |
| Interest Coverage Ratio: 1.71 > 6 (EBITDA TTM 53.7m / Interest Expense TTM 5.09m) |
| A: 0.05 (Total Current Assets 49152.86b - Total Current Liabilities 34131.51b) / Total Assets 276018.72b |
| B: -0.00 (Retained Earnings -3.97m / Total Assets 276018.72b) |
| C: 0.00 (EBIT TTM 8.69m / Avg Total Assets 138009.48b) |
| D: 0.00 (Book Value of Equity 253.77b / Total Liabilities 70702.47b) |
| Altman-Z'' Score: 0.36 = B |
Over the past week, the price has changed by +9.43%, over one month by +28.23%, over three months by +23.76% and over the past year by +174.43%.
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 13.3 | 13.5% |
P/E Forward = 0.7198
P/S = 162.4469
P/B = 1.3351
Revenue TTM = 13.7m USD
EBIT TTM = 8.69m USD
EBITDA TTM = 53.7m USD
Long Term Debt = unknown (0.0)
Short Term Debt = 34131.51b USD (from shortTermDebt, last quarter)
Debt = 34131.51b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -14902.65b USD (from netDebt column, last quarter)
Enterprise Value = 273.9m USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 1.71 (Ebit TTM 8.69m / Interest Expense TTM 5.09m)
EV/FCF = 0.00x (Enterprise Value 273.9m / FCF TTM 4301.46b)
FCF Yield = 1.57m% (FCF TTM 4301.46b / Enterprise Value 273.9m)
FCF Margin = 31.4m% (FCF TTM 4301.46b / Revenue TTM 13.7m)
Net Margin = 356.0% (Net Income TTM 48.8m / Revenue TTM 13.7m)
Gross Margin = 62.89% ((Revenue TTM 13.7m - Cost of Revenue TTM 5.09m) / Revenue TTM)
Gross Margin QoQ = 82.73% (prev 77.43%)
Tobins Q-Ratio = 0.00 (Enterprise Value 273.9m / Total Assets 276018.72b)
Interest Expense / Debt = 0.00% (Interest Expense 1.28m / Debt 34131.51b)
Taxrate = 21.0% (US default 21%)
NOPAT = 6.87m (EBIT 8.69m * (1 - 21.00%))
Current Ratio = 1.44 (Total Current Assets 49152.86b / Total Current Liabilities 34131.51b)
Debt / Equity = 0.17 (Debt 34131.51b / totalStockholderEquity, last quarter 205316.25b)
Debt / EBITDA = -277k (out of range, set to none) (Net Debt -14902.65b / EBITDA 53.7m)
Debt / FCF = -3.46 (Net Debt -14902.65b / FCF TTM 4301.46b)
Total Stockholder Equity = 51329.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.00% (Net Income 48.8m / Total Assets 276018.72b)
RoE = 0.00% (Net Income TTM 48.8m / Total Stockholder Equity 51329.21b)
RoCE = 0.00% (EBIT 8.69m / Capital Employed (Equity 51329.21b + L.T.Debt 0.0))
RoIC = 2.49% (NOPAT 6.87m / Invested Capital 275.8m)
WACC = 0.00% (E(273.9m)/V(34131.78b) * Re(10.38%) + D(34131.51b)/V(34131.78b) * Rd(0.00%) * (1-Tc(0.21)))
Discount Rate = 10.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 6.80%
[DCF] Terminal Value 80.82% ; FCFF base≈2580.88b ; Y1≈1694.47b ; Y5≈774.89b
[DCF] Fair Price = 1.56m (EV 24596.98b - Net Debt -14902.65b = Equity 39499.63b / Shares 25.4m; r=6.0% [WACC]; 5y FCF grow -40.0% → 3.0% )
[DCF] Fair Price = 1.56m (out of range, set to none)
EPS Correlation: 33.16 | EPS CAGR: -6.82% | SUE: 0.00 | # QB: 0
Revenue Correlation: 27.56 | Revenue CAGR: 96.82% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-06-30): EPS=-0.15 | Chg7d=-0.015 | Chg30d=-0.015 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=-0.67 | Chg7d=-0.015 | Chg30d=-0.015 | Revisions Net=+0 | Growth EPS=+0.0% | Growth Revenue=-3.8%
EPS next Year (2027-12-31): EPS=-0.72 | Chg7d=-0.080 | Chg30d=-0.080 | Revisions Net=-1 | Growth EPS=-8.3% | Growth Revenue=+0.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -6.1% (Discount Rate 10.4% - Earnings Yield 16.5%)
[Growth] Growth Spread = +148.5% (Analyst 142.4% - Implied -6.1%)